In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

[EX Q]: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Affordable Prescription Drugs Act''.

SEC. 2. COMPULSORY LICENSING OF CERTAIN PATENTED MEDICAL INVENTIONS.

(a) In General.--Chapter 14 of title 35, United States Code, is
amended by adding at the end the following:
''Sec. 158. Compulsory licensing
''(a) Compulsory Licensing of Certain Patented Medical
Inventions.--In the case of any subject invention relating to health in
which a patent holder, contractor, exclusive licensee, or assignee has
acquired title under this title, the Secretary of Health and Human
Services shall have the right to establish other use of the subject
matter of the patent without authorization of the right holder if the
Secretary makes the determination described in subsection (b).
''(b) Determination.--The determination of the Secretary of Health
and Human Services referred to in subsection (a) is a determination
that--
''(1) the patent holder, contractor, licensee, or assignee
referred to in subsection (a) has not taken, or is not expected
to take within a reasonable time, effective steps to achieve
practical application of the subject invention in a field of
use;
''(2) such compulsory license is necessary to alleviate
health or safety needs which are not adequately satisfied by
the patent holder, contractor, licensee, or assignee; or
''(3) the patented material is priced higher than may be
reasonably expected based on criteria developed by the
Secretary of Commerce.
''(c) Factors in Authorizing Other Use.--In exercising the right
under subsection (a) to authorize other use of the subject matter of a
patent, the following shall apply:
''(1) Authorization of such use shall be considered on its
individual merits.
''(2) Such use may only be permitted if, prior to such use,
the proposed user has made efforts to obtain authorization from
the right holder on reasonable commercial terms and conditions
and that such efforts have not been successful within a
reasonable period of time. This requirement may be waived in
the case of a national emergency or other circumstances of
extreme urgency or in cases of public noncommercial use. In
situations of national emergency or other circumstances of
extreme urgency, the right holder shall, nevertheless, be
notified as soon as reasonably practicable. In the case of
public noncommercial use, where the Government or (if
applicable) a contractor of the Government, without making a
patent search, knows or has demonstrable grounds to know that a
valid patent is or will be used by or for the Government, the
right holder shall be informed promptly.
''(3) Such use shall be nonexclusive.
''(4) Such use shall be nonassignable, except with that
part of the enterprise or goodwill which enjoys such use.
''(5) Authorization for such use shall be liable, subject
to adequate protection of the legitimate interests of the
persons so authorized, to be terminated if and when the
circumstances which led to it cease to exist and are unlikely
to recur. The competent authority shall have the authority to
review, upon appropriate request, the continued existence of
such circumstances.
''(6) The right holder shall be paid adequate remuneration
in the circumstances of each case, taking into account the
economic value of the authorization.
''(7) The legal validity of any decision relating to the
authorization of such use shall be subject to judicial review
or other independent review by a distinct Federal authority.
''(8) Any decision relating to the remuneration provided in
respect of such use shall be subject to judicial review or
other independent review by a distinct Federal authority.
''(9) The condition set forth in paragraph (2) is not
applicable where such use is permitted to remedy a practice
determined after judicial or administrative process to be
anticompetitive. The need to correct anticompetitive practices
may be taken into account in determining the amount of
remuneration in such cases. The competent authorities shall
have the authority to refuse termination of authorization if
and when the conditions which led to such authorization are
likely to recur.
''(10) Where such use is authorized to permit the
exploitation of a patent ('the 2nd patent') which cannot be
exploited without infringing another patent ('the 1st patent'),
the following additional conditions shall apply:
''(A) The invention claimed in the 2nd patent shall
involve an important technical advance of considerable
economic significance in relation to the invention
claimed in the 1st patent.
''(B) The owner of the 1st patent shall be entitled
to a cross-license on reasonable terms to use the
invention claimed in the 2nd patent.
''(C) The use authorized in respect of the 1st
patent shall be nonassignable except with the
assignment of the 2nd patent.
''(d) Consistency With TRIPS.--Regulations adopted under subsection
(a) shall be consistent with provisions of the Agreement on Trade-
Related Aspects of Intellectual Property Rights referred to in section
101(d)(15) of the Uruguay Round Agreements Act.''.
(b) Conforming Amendment.--the table of contents for chapter 14 of
title 35, United States Code, is amended by adding at the end the
following new item:

''158. Compulsory licensing.''.

SEC. 3. REPORT ON PHARMACEUTICAL COSTS AND SALES.

(a) Report Requirement.--Any person engaged in the manufacture and
sale of any drug approved under section 505 or 512 of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C. 355, 360b) for which a patent is
still in effect shall report to the Congress annually an audit of all
financial information relevant to the pricing of that drug nationally
and internationally, including the costs of research and development,
sufficient to assess the reasonableness of that pricing, in accordance
with specifications developed by the Secretary of Commerce in
consultation with the Commissioner of Food and Drugs.
(b) Disqualification From Participation in Federal Programs as
Penalty for Noncompliance.--In the case of a person who the Secretary
of Commerce determines has failed to submit a report required under
subsection (a) on a timely basis, the person shall be ineligible to
receive payment from the Federal Government or under any Federal
program (including under the medicare and medicaid programs) for any
prescription drug or biologic it manufactures or sells until the date
the Secretary determines that such failure has ceased.
[EX A]: Requires any person engaged in the manufacture and sale of any new drug or new animal drug approved under the Federal Food, Drug, and Cosmetic Act, for which a patent is still in effect, to report annually to Congress an audit of all financial information relevant to that drug's pricing nationally and internationally, including research and development costs, sufficient to assess the reasonableness of that pricing. Requires disqualification from participation in Federal programs as a penalty for noncompliance with this reporting requirement.

[EX Q]: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Empowering Jobs Act of 2015''.

SEC. 2. MODIFICATION OF RULES FOR TAX-EXEMPT ENTERPRISE ZONE FACILITY
BONDS.

(a) In General.--Clause (i) of section 1394(b)(3)(B) of the
Internal Revenue Code of 1986 is amended--
(1) by striking ''References'' and inserting the following:
''(I) In general.--Except as
provided in subclause (II),
references'', and
(2) by adding at the end the following new subclause:
''(II) Special rule for employee
residence test.--For purposes of
subsection (b)(6) and (c)(5) of section
1397C, an employee shall be treated as
a resident of an empowerment zone if
such employee is a resident of an
empowerment zone, an enterprise
community, or a qualified low-income
community within an applicable
nominating jurisdiction.''.
(b) Definitions.--
(1) Qualified low-income community.--Paragraph (3) of
section 1394(b) of the Internal Revenue Code of 1986 is amended
by redesignating subparagraphs (C) and (D) as subparagraphs (D)
and (E), respectively, and by inserting after subparagraph (B)
the following new subparagraph:
''(C) Qualified low-income community.--For purposes
of subparagraph (B)--
''(i) In general.--The term 'qualified low-
income community' means any population census
tract if--
''(I) the poverty rate for such
tract is at least 20 percent, or
''(II) the median family income for
such tract does not exceed 80 percent
of statewide median family income (or,
in the case of a tract located within a
metropolitan area, metropolitan area
median family income if greater).
Subclause (II) shall be applied using
possessionwide median family income in the case
of census tracts located within a possession of
the United States.
''(ii) Targeted populations.--The Secretary
shall prescribe regulations under which 1 or
more targeted populations (within the meaning
of section 103(20) of the Riegle Community
Development and Regulatory Improvement Act of
1994) may be treated as a qualified low-income
communities.
''(iii) Areas not within census tracts.--In
the case of an area which is not tracted for
population census tracts, the equivalent county
divisions (as defined by the Bureau of the
Census for purposes of defining poverty areas)
shall be used for purposes of determining
poverty rates and median family income.
''(iv) Modification of income requirement
for census tracts within high migration rural
counties.--
''(I) In general.--In the case of a
population census tract located within
a high migration rural county, clause
(i)(II) shall be applied to areas not
located within a metropolitan area by
substituting '85 percent' for '80
percent'.
''(II) High migration rural
county.--For purposes of this clause,
the term 'high migration rural county'
means any county which, during the 20-
year period ending with the year in
which the most recent census was
conducted, has a net out-migration of
inhabitants from the county of at least
10 percent of the population of the
county at the beginning of such
period.''.
(2) Applicable nominating jurisdiction.--Subparagraph (D)
of section 1394(b)(3) of such Code, as redesignated by
paragraph (1), is amended by adding at the end the following
new clause:
''(iii) Applicable nominating
jurisdiction.--The term 'applicable nominating
jurisdiction' means, with respect to any
empowerment zone or enterprise community, any
local government that nominated such community
for designation under section 1391.''.
(c) Conforming Amendments.--
(1) Clause (iii) of section 1394(b)(3)(B) of such Code is
amended by striking ''or an enterprise community'' and
inserting '', an enterprise community, or a qualified low-
income community within an applicable nominating
jurisdiction''.
(2) Subparagraph (D) of section 1394(b)(3) of such Code, as
redesignated by subsection (b)(1), is amended by striking
''Definitions'' and inserting ''Other definitions''.
(d) Effective Date.--The amendments made by this section shall
apply to bonds issued before, on, or after the date of the enactment of
this Act and not redeemed before the date of the enactment of this Act.

SEC. 3. EXTENSION OF EMPOWERMENT ZONE TAX INCENTIVES.

(a) In General.--Clause (i) of section 1391(d)(1)(A), as amended by
the Tax Increase Prevention Act of 2014, is amended by striking
''December 31, 2014'' and inserting ''December 31, 2016''.
(b) Treatment of Certain Termination Dates Specified in
Nominations.--In the case of a designation of an empowerment zone the
nomination for which included a termination date which is
contemporaneous with the date specified in subparagraph (A)(i) of
section 1391(d)(1) of the Internal Revenue Code of 1986 (as in effect
before the enactment of this Act), subparagraph (B) of such section
shall not apply with respect to such designation if, after the date of
the enactment of this section, the entity which made such nomination
amends the nomination to provide for a new termination date in such
manner as the Secretary of the Treasury (or the Secretary's designee)
may provide.
(c) Effective Dates.--The amendment made by subsection (a) shall
apply to periods after December 31, 2014.
[EX A]: Empowering Jobs Act of 2015 Amends the Internal Revenue Code, with respect to tax-exempt enterprise zone facility bonds and empowerment zones, to: (1)include as employees of a qualified business entity employees who are residents ofan empowerment zone, an enterprise community, or a qualified low-income community; and (2)extend the period of designation for empowerment zones through December 31, 2016 (thus extending the eligibility of such zones for certain tax benefits).

[EX Q]: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Shareholder Empowerment Act of
2009''.

SEC. 2. MAJORITY VOTING FOR DIRECTORS.

The Securities Exchange Act of 1934 is amended by adding after
section 16 the following new section:

''SEC. 16A. ELECTION OF DIRECTORS.

''(a) Standards Relating to Election of Directors.--
''(1) Commission rules.--Not later than 270 days after the
date of enactment of this section, the Commission shall, by
rule, direct the national securities exchanges and national
securities associations to prohibit the listing of any security
of an issuer that is not in compliance with the requirements of
any portion of paragraph (2). Such rules shall provide for
appropriate procedures for an issuer to have an opportunity to
cure any defects that would be the basis for such a prohibition
before the imposition of such prohibition.
''(2) Standards for election of directors.--
''(A) Majority voting.--Each issuer shall, to the
extent permitted under State law, provide in its
governing documents that--
''(i) directors in uncontested elections
shall be elected by a majority of the votes
cast as to each nominee; and
''(ii) in contested elections where the
number of nominees exceeds the number of
directors to be elected, directors shall be
elected by the vote of a plurality of the
shares represented at any meeting and entitled
to vote on the election of directors.
''(B) Resignation policy.--Each issuer shall also,
to the extent permitted under State law, adopt
procedures under which any director who is not elected
to a new term shall offer to tender his or her
resignation to the board of directors. The board of
directors, with the advice of a committee of the board
if such a committee has been established for that
purpose, shall determine what action should be taken as
to that resignation and shall publicly disclose its
decision and the rationale for that decision within a
reasonable period after certification of the election
results.
''(b) Shareholder Access to the Proxy in Director Elections.--
''(1) Rule.--Not later than 270 days after the date of
enactment of this section, the Commission shall, by rule,
require that in proxy statements and proxies, authorizations or
consents prepared by an issuer pursuant to section 14, the
issuer shall identify and provide security holders with an
opportunity to vote on candidates for the board of directors
who have been nominated by holders in the aggregate at least 1
percent of the issuer's voting securities for at least 2 years
prior to a record date established by the issuer for a meeting
of security holders.
''(2) Application.--This rule shall specify the information
to be provided to an issuer by security holders who nominate
candidates for inclusion in an issuer's proxy materials under
this section and shall require the issuer to disclose
information about such candidates in the issuer's proxy
materials to the same extent that information must be disclosed
about candidates nominated by the issuer. This rule shall apply
only when eligible security holders have nominated fewer than a
majority of the number of directors then authorized to serve on
the board of directors, and the rule shall specify procedures
to be followed if different security holders nominate
candidates sufficient to constitute a majority of the board of
directors.
''(3) Effective date.--The rule shall apply to proxy voting
for meetings of security holders held on or after January 1,
2010, except to the extent that a meeting was originally
scheduled to be held in 2009, but was adjourned to 2010.
''(c) Broker Discretionary Voting in Uncontested Director
Elections.--Not later than 270 days after the date of enactment of this
section, the Commission shall by, rule, require that a broker shall not
be allowed to vote securities on an uncontested election to the board
of directors of an issuer to the extent that the beneficial owner of
those securities has not provided specific instructions to the broker.
The rule shall apply to proxy voting for meetings of security holders
held on or after January 1, 2010, except to the extent that a meeting
was originally scheduled to be held in 2009, but was adjourned to 2010.
''(d) Independent Chairman of the Board of Directors.--
''(1) Commission rules.--Not later than 270 days after the
date of enactment of this section, the Commission shall, by
rule, direct the national securities exchanges and national
securities associations to prohibit the listing of any security
of an issuer that is not in compliance with the requirements of
any portion of paragraph (2). Such rules shall provide for
appropriate procedures for an issuer to have an opportunity to
cure any defects that would be the basis for such a prohibition
before the imposition of such prohibition.
''(2) Independent chairman of the board of directors.--Each
issuer shall provide in its governing documents or a public
statement of corporate policy that, to the extent possible and
consistent with the issuer's status as a publicly traded
company, the chairman of the board of directors shall be an
independent director who has not previously served as an
executive officer of the issuer. Such rule shall be implemented
with due regard for contracts in existence on the date of
enactment of this section. For purposes of this subsection, an
'independent director' shall be one who during the preceding 5
years has not been--
''(A) employed by the issuer in an executive
capacity;
''(B) an employee, director or owner greater than
20 percent of the beneficial shares of a firm that is a
paid adviser or consultant to the issuer;
''(C) employed by a significant customer or
supplier of the issuer;
''(D) a party to a personal services contract with
the issuer, as well as with the issuer's Chair, chief
executive officer, or other senior executive officer;
''(E) an employee, officer or director of a
foundation, university or other non-profit organization
that receives the greater of $100,000 or 1 percent of
total annual donations from the issuer;
''(F) a relative of an executive of the issuer;
''(G) part of an interlocking directorate in which
the issuer's chief executive officer or another
executive serves on the board of another issuer
employing that director; and
''(H) engaged in any other relationship with the
issuer or senior executives that the Commission
determines would not render that director an
independent director.''.

SEC. 3. EXECUTIVE COMPENSATION REQUIREMENTS.

The Securities Exchange Act of 1934 is further amended by adding
after the section 16A, as added by section 2, the following new section

''SEC. 16B. EXECUTIVE COMPENSATION REQUIREMENTS.

''(a) Shareholder Approval of Executive Compensation.--
''(1) Annual shareholder vote on executive compensation.--
Any proxy or consent or authorization for an annual or other
meeting of an issuer shall permit a separate vote by
shareholders to approve the compensation of senior executive
officers, as disclosed pursuant to the compensation disclosure
rules of the Commission (which disclosure shall include the
compensation discussion and analysis, the compensation tables,
and any related material).
''(2) Non-binding nature of vote.--A shareholder vote
described in paragraph (1) shall not be binding on the board of
directors of an issuer and may not be construed as overruling a
decision by such board, nor to create or imply any additional
fiduciary duty by such board, nor shall such vote be construed
to restrict or limit the ability of security holders to make
proposals for inclusion in proxy materials related to executive
compensation.
''(3) Deadline for rules.--Not later than 1 year after the
date of enactment of this section, the Commission shall issue
any final rules and regulations required by this section.
''(4) Exception.--This provision shall not apply to any
issuer who is subject to a similar recoupment requirement under
another provision of Federal law.
''(b) Independent Compensation Advisers.--
''(1) Requirement.--Not later than 1 year after the date of
enactment of this section, the Commission shall, by rule,
require that if an issuer's board of directors or a committee
thereof retains an individual adviser or advisory firm in
conjunction with negotiating employment contracts or
compensation agreements with the issuer's executives, the
individual adviser and his or her firm shall be independent of
the issuer, its executives and directors, and shall report
solely to the board of directors or the committee thereof
responsible for executive compensation. The rule shall further
require that issuers shall not agree to indemnify or limit the
liability of compensation advisers or advisory firms.
''(2) Determination.--In determining the extent to which an
adviser or advisory firm is independent of an issuer within the
meaning of this section, the Commission shall consider such
matters as--
''(A) the extent (as measured by annual fees and
other relevant metrics) to which an individual adviser
or advisory firm provides services in conjunction with
negotiating employment contracts or compensation
agreements with the issuer's executives, as compared to
other services that the adviser or advisory firm
provides to the issuer or executives;
''(B) whether individual advisers are permitted to
hold equity and do hold equity in the issuer; and
''(C) whether an advisory firm's incentive
compensation plan links the compensation of individual
advisers to the advisory firm's provision of other
services to the issuer.
''(c) Clawbacks of Unearned Performance-Based Pay.--
''(1) Commission rules.--Not later than 270 days after the
date of enactment of this section, the Commission shall, by
rule, direct the national securities exchanges and national
securities associations to prohibit the listing of any security
of an issuer that is not in compliance with the requirements of
any portion of paragraph (2). Such rules shall provide for
appropriate procedures for an issuer to have an opportunity to
cure any defects that would be the basis for such a prohibition
before the imposition of such prohibition.
''(2) Recoupment of unearned compensation.--An issuer's
board of directors or a committee thereof shall develop and
disclose a policy for reviewing unearned bonus payments,
incentive payments, or equity payments that were awarded to
executive officers owing to fraud, financial results that
require restatement, or some other cause. The policy should
require recovery or cancellation of any unearned payments to
the extent that it is feasible and practical to do so.
''(3) Exception.--This provision shall not apply to any
issuer who is subject to a similar recoupment requirement under
another provision of Federal law.
''(d) Severance Agreements Tied to Performance.--
''(1) Commission rules.--Not later than 270 days after the
date of enactment of this section, the Commission shall, by
rule, direct the national securities exchanges and national
securities associations to prohibit the listing of any security
of an issuer that is not in compliance with the requirements of
any portion of paragraph (2). Such rules shall provide for
appropriate procedures for an issuer to have an opportunity to
cure any defects that would be the basis for such a prohibition
before the imposition of such prohibition.
''(2) Severance agreements tied to performance.--An
issuer's board of directors or a committee thereof shall not
enter into agreements providing for severance payments to a
senior executive officer who is terminated because of poor
performance as an executive, as determined by the board of
directors. To the extent that an issuer is able to terminate a
senior executive officer for cause, poor performance by the
executive, as determined by the board of directors, shall be
considered as one such cause. The rule shall be implemented
with due regard for contracts in existence on the date of
enactment of this section.
''(e) Improved Disclosure of Compensation Targets.--Not later than
1 year after the date of enactment of this section, the Commission
shall, by rule, require additional disclosure of specific performance
targets that are used by issuers to determine a senior executive
officer's eligibility for bonuses, equity and incentive compensation.
The Commission shall consider methods to improve disclosure in
situations when it is claimed that disclosure would result in
competitive harm to the issuer, including, requirements that the issuer
describe its past experience with similar target levels, disclose any
inconsistencies between compensation targets and targets set in other
contexts, submit a request for confidential treatment of the
performance targets under Commission rules, or disclose the data after
disclosure would no longer be considered competitively harmful.''.
[EX A]:
Shareholder Empowerment Act of 2009 - Amends the Securities Exchange Act of 1934 to direct the Securities and Exchange Commission (SEC) to prohibit national securities exchanges and associations from listing the securities of any issuer unless, to the extent permitted by state law, such issuer requires: (1) the election of directors who receive the majority of votes in uncontested elections or a plurality of votes in contested elections; and (2) directors who are not reelected to offer to tender their resignations.

Directs the SEC to: (1) require issuers to identify and provide security holders with an opportunity to vote on director candidates who have been nominated by holders of at least 1% of the issuer's voting securities for at least two years, provided security holders have nominated fewer than a majority of the directors then authorized to serve; (2) prohibit brokers from voting securities on an uncontested election to the board of directors without having received specific instructions from the securities' beneficial owners; and (3) requires listed issuers, to the extent possible, to have an independent chairman of their board of directors who has not served as an executive of the issuer.

Requires any proxy or consent or authorization for an annual or other meeting of a securities issuer to permit a separate shareholder vote on executive compensation, though such vote shall not be binding on its board of directors.

Directs the SEC to direct the national securities exchanges and national securities associations to prohibit: (1) issuers from retaining advisors in negotiating executive employment or compensation agreements that are not independent or are protected from liability by such issuers; (2) the listing of issuers that do not have a (clawback) policy of recovering executive payments that were unearned due to fraud, faulty financial statements, or some other cause; and (3) the listing of issuers that provide severance payments to senior executives who are terminated for poor performance.

Directs the SEC to require additional disclosure of specific performance targets issuers use in determining a senior executive's eligibility for bonuses, equity, and incentive compensation.